References - Therapeutic Strategies in Cancer Biology and Pathology - page 247

Shih, Y.P., Takada, Y., Lo, S.H., 2012. Silencing of DLC1 upregulates PAI-1 expression and
reduces migration in normal prostate cells. Mol. Cancer Res. 10, 34-39.
Shin, H., Kim, J.H., Lee, Y.S., Lee, Y.C., 2012. Change in gene expression profiles of secreted
frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of pro-
moter demethylation and histone modification causing inhibition of Wnt signaling. Int. J.
Oncol. 40, 1533-1542.
Shin, I., Kim, S., Song, H., Kim, H.R.C., Moon, A., 2005. H-ras-specific activation of Rac-
MKK3/6-p38 pathway - its critical role in invasion and migration of breast epithelial
cells. J. Biol. Chem. 280, 14675-14683.
Shin, K.H., Bae, S.D., Hong, H.S., Kim, R.H., Kang, M.K., Park, N.H., 2011. miR-181a
shows tumor suppressive effect against oral squamous cell carcinoma cells by downregu-
lating K-ras. Biochem. Biophys. Res. Commun. 404, 896-902.
Shinawi, T., Hill, V., Dagklis, A., Baliakas, P., Stamatopoulos, K., Agathanggelou, A., et al.,
2012. KIBRA gene methylation is associated with unfavorable biological prognostic
parameters in chronic lymphocytic leukemia. Epigenetics 7, 211-215.
Shoji, S., Tang, X.Y., Umemura, S., Itoh, J., Takekoshi, S., Shima, M., et al., 2009. Metastin
inhibits migration and invasion of renal cell carcinoma with overexpression of metastin
receptor. Eur. Oncol. 55, 441-451.
Shoji, S., Tang, X.Y., Sato, H., Usui, Y., Uchida, T., Terachi, T., 2010. Metastin has potential
as a suitable biomarker and novel effective therapy for cancer metastasis (review). Oncol.
Lett. 1, 783-788.
Shorning, B.Y., Griffiths, D., Clarke, A.R., 2011. Lkb1 and Pten synergise to suppress mTOR-
mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder.
PloS ONE 6, e16209.
Si, M.L., Zhu, S., Wu, H., Lu, Z., Wu, F., Mo, Y.Y., 2007. miR-21-mediated tumor growth.
Oncogene 26, 2799-2803.
Sibold, S., Roh, V., Keogh, A., Studer, P., Tiffon, C., Angst, E., et al., 2007. Hypoxia increases
cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in
human hepatocellular carcinoma. FEBS Lett. 58, 989-994.
Silber, J., Lim, D.A., Petritsch, C., Persson, A.I., Maunakea, A.K., Yu, M., et al., 2008. miR-
124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differ-
entiation of brain tumor stem cells. BMC Med. 6, 14.
Simooka, H., Oyama, T., Sano, T., Horiguchi, J., Nakajima, T., 2004. Immunohistochemical
analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast
lesions, with particular reference to early carcinogenesis. Pathol. Int. 54, 595-602.
Singh, N.K., Rao, P., Asea, A., 2008. Silencing F metastasis-associated gene 1 (MTA1) stim-
ulates Hsp70 cellular release and neurite extension in neuroblastoma cells. Heat Shock
Proteins 3, 273-282.
Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., et al., 2004.
Identification of human brain tumour initiating cells. Nature 432, 396-401.
Skulic, A., Migden, M.R., Oro, A.E., Dirix, L., Lewis, K.D., Hainsworth, J.D., et al., 2012.
Efficacy and safety of vismodegrib in advanced basal cell carcinoma. New Engl. J. Med.
366, 2171-2179.
Skvara, H., Kalthoff, F., Meingassner, J.G., Wolff-Winiski, B., Aschauer, H., Kelleher, J.F.,
et al., 2011. Topical treatment of basal cell carcinomas in nevoid basal cell carcinoma
syndrome with a Smoothened inhibitor. J. Invest. Dermatol. 131, 1735-1744.
Slipicevic, A., Holm, R., Emilsen, E., Rosnes, A.K.R., Welch, D.R., Maelandsmo, G.M.,
et al., 2012. Cytoplasmic BRMS1 expression in malignant melanoma is associated with
increased disease-free survival. BMC Cancer 12, 73.